12/15 studies (80%) reported significantly higher CXCL10 levels in vitiligo patients compared to controls, resulting in an overall highly significant CXCL10 concentration in the blood of vitiligo patients (P < 0.00001) (13–20, 22, 23, 25–28). This evidence concerns the gene CXCL10 and vitiligo.